These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 967232

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sustained release of naltrexone from glyceride implants.
    Sullivan MF, Kalkward DR.
    Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):27-32. PubMed ID: 1234982
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Use of synthetic polypeptides in the preparation of biodegradable delivery vehicles for narcotic antagonists.
    Sidman KR, Arnold DL, Steber WD, Nelsen L, Granchelli FE, Strong P, Sheth SG.
    Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):33-8. PubMed ID: 1234983
    [Abstract] [Full Text] [Related]

  • 6. Development of Chronomers for narcotic antagonists.
    Capozza RC, Schmitt EE, Sendelbeck LR.
    Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):39-42. PubMed ID: 13306
    [Abstract] [Full Text] [Related]

  • 7. Solid solutions as long-acting naltrexone delivery systems.
    Olsen JL.
    NIDA Res Monogr; 1981; 28():265-71. PubMed ID: 6791010
    [Abstract] [Full Text] [Related]

  • 8. An improved long-acting delivery system for narcotic antagonists.
    Misra AL, Pontani RB.
    NIDA Res Monogr; 1981; 28():254-64. PubMed ID: 6791009
    [Abstract] [Full Text] [Related]

  • 9. Testing of drug delivery systems for use in the treatment of narcotic addiction.
    Reuning RH, Malspeis L, Frank S, Notari RE.
    Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):43-5. PubMed ID: 827709
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Development of Chronomers tm for narcotic antagonists.
    Capozza RC, Schmitt EE, Seńdelbeck LR.
    Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):39-42. PubMed ID: 967234
    [Abstract] [Full Text] [Related]

  • 14. Narcotic antagonists: naltrexone pharmacochemistry and sustained-release preparations.
    NIDA Res Monogr; 1981 Jan; 28():1-273. PubMed ID: 6790998
    [No Abstract] [Full Text] [Related]

  • 15. Development of drug delivery systems for use in treatment of narcotic addiction.
    Sharon AC, Wise DL.
    NIDA Res Monogr; 1981 Jan; 28():194-213. PubMed ID: 6791005
    [Abstract] [Full Text] [Related]

  • 16. Use of synthetic polypeptides in the preparation of biodegradable delivery vehicles for narcotic antagonists.
    Sidman KR, Arnold DL, Steber WD, Nelsen L, Granchelli FE, Strong P, Sheth SG.
    Natl Inst Drug Abuse Res Monogr Ser; 1976 Jan; (4):33-8. PubMed ID: 967233
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic quantitation of naltrexone release from several sustained-release delivery systems.
    Reuning RH, Liao SH, Staubus AE.
    NIDA Res Monogr; 1981 Jan; 28():172-84. PubMed ID: 6791003
    [Abstract] [Full Text] [Related]

  • 18. Naltrexone, morphine and cocaine interactions in mice and rats.
    Blumberg H, Ikeda C.
    J Pharmacol Exp Ther; 1978 Aug; 206(2):303-10. PubMed ID: 682114
    [No Abstract] [Full Text] [Related]

  • 19. The development of sustained action preparations of narcotic antagonists.
    Willette RE.
    NIDA Res Monogr; 1976 Sep; (9):31-4. PubMed ID: 1004531
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.